Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.710
-0.010 (-0.58%)
At close: Aug 8, 2025, 4:00 PM
1.750
+0.040 (2.34%)
After-hours: Aug 8, 2025, 4:00 PM EDT
Accolade Market Cap
Whitehawk Therapeutics has a market cap or net worth of $80.56 million as of August 8, 2025. Its market cap has increased by 108.70% in one year.
Market Cap
80.56M
Enterprise Value
-96.17M
1-Year Change
108.70%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since August 9, 2017, Whitehawk Therapeutics's market cap has decreased from $162.50M to $80.56M, a decrease of -50.43%. That is a compound annual growth rate of -8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 81.00M | 4.11% |
| Dec 31, 2024 | 77.80M | 57.17% |
| Dec 29, 2023 | 49.50M | -84.19% |
| Dec 30, 2022 | 313.00M | -37.97% |
| Dec 31, 2021 | 504.60M | 992.21% |
| Dec 31, 2020 | 46.20M | 82.61% |
| Dec 31, 2019 | 25.30M | -63.33% |
| Dec 31, 2018 | 69.00M | -46.35% |
| Dec 29, 2017 | 128.60M | -20.86% |
| Aug 9, 2017 | 162.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |